Jessica R Bauman

13PUBLICATIONS
69CO-AUTHORS
Autonomic nervous systemCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGender, sexuality and educationCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Dec 22, 2025
CRESTONE: A Phase II Study of the Efficacy and Safety of the HER3 Monoclonal Antibody, Seribantumab, in Solid Tumors With Neuregulin-1 (NRG1) Fusions.

Tejas Patil, Jessica J Lin, Parneet K Cheema

|May 31, 2025
Phase II (Alliance A091802) Randomized Trial of Avelumab Plus Cetuximab Versus Avelumab Alone in Advanced Cutaneous Squamous Cell Carcinoma.

Dan P Zandberg, Jacob B Allred, Ari J Rosenberg

|Apr 01, 2025
Phase II Trial of Chemotherapy, Cetuximab, and Erlotinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck.

Aarti Bhatia, Ranee Mehra, Jessica Bauman

|Oct 16, 2024
Palbociclib in Patients With Head and Neck Cancer and Other Tumors With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study.

Francis P Worden, Evan Pisick, Michael Rothe

|Feb 06, 2024
Hematology and Oncology Fellow Education About Sexual and Reproductive Health: A Survey of Program Directors in the United States.

Jennifer Barsky Reese, Jessica R Bauman, Kristen A Sorice

|Mar 28, 2023
Randomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck Cancer.

Julie E Bauman, Nabil F Saba, Denise Roe

Pageof 3

Frequent Collaborators

4 joint publications

Thomas J Galloway

3 joint publications

Jeffrey C Liu

2 joint publications

Daniel R Carrizosa

2 joint publications

Natasha Frederick